Tropomyosin Receptor Kinase C (TrkC) Antibody Global Market Report 2025
상품코드:1889606
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
TrkC 항체 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 14억 4,000만 달러로 평가되었고, 2025년에는 16억 2,000만 달러에 달할 것으로 추정되며, CAGR 12.5%로 성장이 예상되고 있습니다. 지난 수년간의 성장은 신경 질환의 유병률 상승, 표적 면역요법의 보급 확대, 단일클론 항체 치료에 대한 수요 증가, 희귀질환 관리에 대한 주목 증가, 신경퇴행성 질환 진단에 대한 인식 향상과 관련이 있습니다.
TrkC 항체 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 25억 6,000만 달러에 달할 것으로 예측되며, CAGR 12.2%로 성장할 전망입니다. 예측 기간의 성장요인으로는 신경종양학 연구에 대한 자금확충, 임상시험 건수 증가, 정밀의료의 보급 확대, 학술기관 및 산업계의 이해관계자 간 연계 강화, 선진 지역에서의 헬스케어 지출 증가를 들 수 있습니다. 예측 기간 중 주요 동향으로는 항체 공학 기술 진보, 바이오마커 구동 진단 기술 진전, 재조합 항체 생산 기술 향상, 단일클론 항체 전달 시스템 혁신, 분자 표적화 및 단백질 발현 기술의 지속적인 개발이 예상됩니다.
신경 질환의 유병률 상승은 TrkC 항체 시장의 성장을 가속할 것으로 예측됩니다. 신경질환은 뇌, 척수, 신경에 영향을 미치며 인지기능장애, 운동기능장애, 감각장애 등 다양한 증상을 유발합니다. 노화는 이러한 질병 증가의 주요 원인이며, 노화와 함께 신경 세포의 점차적인 감소, 뇌가소성의 감소, 산화 스트레스 증가가 발생합니다. 이러한 변화는 신경 퇴행성 질환과 신경 발달 장애의 발병 및 진행에 기여합니다. TrkC 항체는 신경 세포의 성장, 생존 및 분화에 중요한 역할을 하는 TrkC 수용체를 특이적으로 표적으로 함으로써 이러한 질환 치료에 필수적입니다. TrkC 신호전달 경로를 조절함으로써 TrkC 항체는 표적 요법의 개발을 돕고, 알츠하이머병을 비롯한 신경퇴행성 질환의 이해를 증진시키는 데 기여합니다. 예를 들어, 2024년 7월 영국 국민보건서비스(NHS)는 연중반까지 치매로 진단받은 환자 수가 48만 7,432명에 달했으며, 5월에서 3,155건 증가했다고 보고했습니다. 이처럼 신경 질환의 유병률이 증가하고 있는 것이 TrkC 항체 시장의 성장을 뒷받침하고 있습니다.
맞춤형 의료에 대한 수요 증가는 TrkC 항체 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료는 환자의 유전적 요인, 환경 요인, 생활 습관에 따라 치료법을 개별적으로 조정하는 것입니다. 이 접근법은 치료 효과를 최적화하고 의료 품질을 향상시킵니다. 유전체 기술의 진보로 유전적 변이의 정밀한 동정과 맞춤형 치료가 가능하게 되었기 때문에 맞춤형 의료에 대한 수요가 높아지고 있습니다. TrkC 항체는 TrkC 수용체의 검출 및 표적화를 가능하게 함으로써 맞춤형 의료에서 중요한 역할을 하며, 개별 환자에게 특히 적합한 치료의 개발에 활용할 수 있습니다. 치료 개입의 정밀도를 향상시킴으로써, TrkC 항체는 신경 질환이나 암 관련 질환에서 치료 성과의 최적화에 공헌합니다. 예를 들어, 2024년 2월에 개인화된 메디신 연합(PMC)이 보고한 바에 따르면, 미국 식품의약국(FDA)은 2023년에 26건의 새로운 맞춤형 의료를 승인하고, 2022년 12건에서 크게 증가했습니다. 맞춤형 의료에 대한 수요는 TrkC 항체 시장의 성장을 지속적으로 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 TrkC 항체 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 TrkC 항체 시장 : 성장률 분석
세계의 TrkC 항체 시장 실적 : 규모 및 성장(2019-2024년)
세계의 TrkC 항체 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 TrkC 항체 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 TrkC 항체 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단일클론 항체
폴리클로날 항체
재조합 항체
세계의 TrkC 항체 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
기초조사
창약
세계의 TrkC 항체 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제약 및 생명 공학 기업
학술연구기관
진단 실험실
기타 최종 사용자
세계의 TrkC 항체 시장 : 단일클론 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
인간 단일클론 항체
인간화 단일클론 항체
키메라 단일클론 항체
마우스 단일클론 항체
세계의 TrkC 항체 시장 : 폴리클로날 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
동물 유래 폴리클로날 항체
재조합 폴리클로날 항체
혈청 유래 폴리클로날 항체
식물 유래 폴리클로날 항체
세계의 TrkC 항체 시장 : 재조합 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
싱글 체인 가변 영역 항체
항원 결합 항체 단편
전장 재조합 항체
개조 재조합 항체
제7장 지역별 및 국가별 분석
세계의 TrkC 항체 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 TrkC 항체 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
TrkC 항체 시장 : 경쟁 구도
TrkC 항체 시장 : 기업 프로파일
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Becton Dickinson and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
GeneTex Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Techne Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GenScript Biotech Corporation
Cell Signaling Technology Inc.
Sino Biological Inc.
ACROBiosystems Inc.
Proteintech Group Inc.
Abclonal Inc.
OriGene Technologies Inc.
Santa Cruz Biotechnology Inc.
Rockland Immunochemicals Inc.
Novus Biologicals LLC
Abnova Corporation
Aviva Systems Biology Corporation
MyBioSource Inc.
Alomone Labs
LifeSpan BioSciences Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
TrkC 항체 시장(2009년) : 새로운 기회를 제공하는 국가
TrkC 항체 시장(2009년) : 새로운 기회를 제공하는 부문
TrkC 항체 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
A tropomyosin receptor kinase C (TrkC) antibody is a protein engineered to specifically attach to the TrkC receptor, a member of the receptor tyrosine kinase family that plays a key role in neural development, function, and certain disease processes. It is used in research to detect or influence TrkC receptor activity, supporting studies of neurotrophin signaling and immune responses, and is also employed in diagnostic or experimental applications.
The primary product types of tropomyosin receptor kinase C (TrkC) antibody include monoclonal antibodies, polyclonal antibodies, and recombinant antibodies. Monoclonal antibodies (mAbs) are laboratory-produced antibodies that are uniform and designed to recognize a single epitope on a target antigen. They are used in various applications, such as basic research and drug discovery, and serve end users including pharmaceutical and biotechnology companies, academic and research institutions, diagnostic laboratories, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The tropomyosin receptor kinase C (TrkC) antibody market research report is one of a series of new reports from The Business Research Company that provides tropomyosin receptor kinase C (TrkC) antibody market statistics, including tropomyosin receptor kinase C (TrkC) antibody industry global market size, regional shares, competitors with a tropomyosin receptor kinase C (TrkC) antibody market share, detailed tropomyosin receptor kinase C (TrkC) antibody market segments, market trends and opportunities, and any further data you may need to thrive in tropomyosin receptor kinase C (TrkC) antibody industry. This tropomyosin receptor kinase C (TrkC) antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tropomyosin receptor kinase C (TrkC) antibody market size has grown rapidly in recent years. It will grow from $1.44 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. Growth during the historic period can be linked to the rising prevalence of neurological disorders, greater adoption of targeted immunotherapies, increasing demand for monoclonal antibody-based treatments, heightened focus on managing rare diseases, and growing awareness of neurodegenerative disease diagnostics.
The tropomyosin receptor kinase C (TrkC) antibody market size is expected to see rapid growth in the next few years. It will grow to $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. Growth in the forecast period can be attributed to expanding funding for neuro-oncology research, an increasing number of clinical trials, wider adoption of precision medicine, growing collaboration between academic and industry stakeholders, and rising healthcare spending in developed regions. Key trends anticipated for the forecast period include technological progress in antibody engineering, advancements in biomarker-driven diagnostics, improvements in recombinant antibody production, innovations in monoclonal antibody delivery systems, and continued development in molecular targeting and protein expression.
The rising prevalence of neurological disorders is expected to drive the growth of the tropomyosin receptor kinase C (TrkC) antibody market. Neurological disorders affect the brain, spinal cord, and nerves, causing a wide range of symptoms, including cognitive, motor, and sensory impairments. The aging population is a key factor behind the increasing prevalence of these disorders, as aging leads to gradual neuronal decline, reduced brain plasticity, and elevated oxidative stress. These changes contribute to the development and progression of neurodegenerative and neurodevelopmental conditions. TrkC antibodies are essential in treating these disorders by specifically targeting TrkC receptors, which play a critical role in neuronal growth, survival, and differentiation. By modulating TrkC signaling pathways, TrkC antibodies help in the development of targeted therapies and improve the understanding of conditions like Alzheimer's disease and other neurodegenerative diseases. For instance, in July 2024, the National Health Service (NHS) in the UK reported that there were 487,432 patients diagnosed with dementia by mid-year, an increase of 3,155 cases from May. This growing prevalence of neurological disorders is fueling the growth of the TrkC antibody market.
The rise in demand for personalized medicine is expected to boost the growth of the TrkC antibody market. Personalized medicine involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors. This approach optimizes therapeutic outcomes and improves care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and allow for tailored treatments. TrkC antibodies play a crucial role in personalized medicine by enabling the detection and targeting of TrkC receptors, which can be used to develop treatments specifically suited to individual patients. By improving the accuracy of therapeutic interventions, TrkC antibodies help optimize outcomes in neurological and cancer-related disorders. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the U.S. FDA approved 26 new personalized medicines in 2023, a significant increase from 12 approved in 2022. The demand for personalized medicine continues to drive the growth of the TrkC antibody market.
The increasing prevalence of cancer is contributing to the growth of the TrkC antibody market. Cancer prevalence refers to the total number of individuals, both newly diagnosed and previously diagnosed, who are living with a history of cancer at a given time. The rise in cancer prevalence is primarily due to lifestyle-related factors such as poor diet, smoking, alcohol consumption, and environmental pollutants. TrkC antibodies are beneficial in cancer treatment as they target TrkC receptors, which play a role in tumor growth and progression. These antibodies enable precise detection and modulation of tumor growth pathways, leading to more effective and targeted therapies for TrkC-related cancers. According to the Australian Institute of Health and Welfare, the number of cancer cases diagnosed in Australia reached 160,570 in 2022, a 3,789-case increase from the previous year. This growing cancer burden is driving the demand for TrkC antibodies, supporting the development of targeted oncology therapies.
Major companies operating in the tropomyosin receptor kinase c (trkc) antibody market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, GeneTex Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Cell Signaling Technology Inc, Sino Biological Inc., ACROBiosystems Inc., Proteintech Group Inc., Abclonal Inc., OriGene Technologies Inc., Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Novus Biologicals LLC, Abnova Corporation, Aviva Systems Biology Corporation, MyBioSource Inc., Alomone Labs, LifeSpan BioSciences Inc.
North America was the largest region in the tropomyosin receptor kinase C (TrkC) antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tropomyosin receptor kinase C (TrkC) antibody report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tropomyosin receptor kinase C (TrkC) antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tropomyosin receptor kinase C (TrkC) antibody market consists of sales of conjugated antibodies, antibody fragments, custom antibodies, kits, secondary antibodies, and antibody cocktails. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tropomyosin Receptor Kinase C (TrkC) Antibody Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tropomyosin receptor kinase c (trkc) antibody market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tropomyosin receptor kinase c (trkc) antibody ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tropomyosin receptor kinase c (trkc) antibody market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3) By Recombinant Antibodies: Single Chain Variable Fragment Antibodies; Fragment Antigen Binding Antibodies; Full-Length Recombinant Antibodies; Engineered Recombinant Antibodies
Companies Mentioned: Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; GeneTex Inc.; Bio-Techne Corporation; GenScript Biotech Corporation; Cell Signaling Technology Inc; Sino Biological Inc.; ACROBiosystems Inc.; Proteintech Group Inc.; Abclonal Inc.; OriGene Technologies Inc.; Santa Cruz Biotechnology Inc.; Rockland Immunochemicals Inc.; Novus Biologicals LLC; Abnova Corporation; Aviva Systems Biology Corporation; MyBioSource Inc.; Alomone Labs; LifeSpan BioSciences Inc.
Countries:
Table of Contents
1. Executive Summary
2. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Characteristics
3. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Trends And Strategies
4. Tropomyosin Receptor Kinase C (TrkC) Antibody Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Growth Analysis And Strategic Analysis Framework
5.1. Global Tropomyosin Receptor Kinase C (TrkC) Antibody PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market Growth Rate Analysis
5.4. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Total Addressable Market (TAM)
6. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Segmentation
6.1. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
6.2. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Basic Research
Drug Discovery
6.3. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institutes
Diagnostic Laboratories
Other End-Users
6.4. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Monoclonal Antibodies
Humanized Monoclonal Antibodies
Chimeric Monoclonal Antibodies
Murine Monoclonal Antibodies
6.5. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Animal-Derived Polyclonal Antibodies
Recombinant Polyclonal Antibodies
Serum-Based Polyclonal Antibodies
Plant-Derived Polyclonal Antibodies
6.6. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Sub-Segmentation Of Recombinant Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Chain Variable Fragment Antibodies
Fragment Antigen Binding Antibodies
Full-Length Recombinant Antibodies
Engineered Recombinant Antibodies
7. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Regional And Country Analysis
7.1. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Tropomyosin Receptor Kinase C (TrkC) Antibody Market
8.1. Asia-Pacific Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tropomyosin Receptor Kinase C (TrkC) Antibody Market
9.1. China Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
9.2. China Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tropomyosin Receptor Kinase C (TrkC) Antibody Market
10.1. India Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tropomyosin Receptor Kinase C (TrkC) Antibody Market
11.1. Japan Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
11.2. Japan Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tropomyosin Receptor Kinase C (TrkC) Antibody Market
12.1. Australia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tropomyosin Receptor Kinase C (TrkC) Antibody Market
13.1. Indonesia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tropomyosin Receptor Kinase C (TrkC) Antibody Market
14.1. South Korea Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
14.2. South Korea Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market
15.1. Western Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
15.2. Western Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tropomyosin Receptor Kinase C (TrkC) Antibody Market
16.1. UK Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Tropomyosin Receptor Kinase C (TrkC) Antibody Market
17.1. Germany Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tropomyosin Receptor Kinase C (TrkC) Antibody Market
18.1. France Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tropomyosin Receptor Kinase C (TrkC) Antibody Market
19.1. Italy Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tropomyosin Receptor Kinase C (TrkC) Antibody Market
20.1. Spain Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market
21.1. Eastern Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
21.2. Eastern Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tropomyosin Receptor Kinase C (TrkC) Antibody Market
22.1. Russia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tropomyosin Receptor Kinase C (TrkC) Antibody Market
23.1. North America Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
23.2. North America Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tropomyosin Receptor Kinase C (TrkC) Antibody Market
24.1. USA Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
24.2. USA Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Tropomyosin Receptor Kinase C (TrkC) Antibody Market
25.1. Canada Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
25.2. Canada Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tropomyosin Receptor Kinase C (TrkC) Antibody Market
26.1. South America Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
26.2. South America Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tropomyosin Receptor Kinase C (TrkC) Antibody Market
27.1. Brazil Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tropomyosin Receptor Kinase C (TrkC) Antibody Market
28.1. Middle East Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
28.2. Middle East Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tropomyosin Receptor Kinase C (TrkC) Antibody Market
29.1. Africa Tropomyosin Receptor Kinase C (TrkC) Antibody Market Overview
29.2. Africa Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tropomyosin Receptor Kinase C (TrkC) Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Competitive Landscape And Company Profiles
30.1. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Competitive Landscape
30.2. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Company Profiles
30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
30.2.4. GeneTex Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Tropomyosin Receptor Kinase C (TrkC) Antibody Market Other Major And Innovative Companies
31.1. GenScript Biotech Corporation
31.2. Cell Signaling Technology Inc.
31.3. Sino Biological Inc.
31.4. ACROBiosystems Inc.
31.5. Proteintech Group Inc.
31.6. Abclonal Inc.
31.7. OriGene Technologies Inc.
31.8. Santa Cruz Biotechnology Inc.
31.9. Rockland Immunochemicals Inc.
31.10. Novus Biologicals LLC
31.11. Abnova Corporation
31.12. Aviva Systems Biology Corporation
31.13. MyBioSource Inc.
31.14. Alomone Labs
31.15. LifeSpan BioSciences Inc.
32. Global Tropomyosin Receptor Kinase C (TrkC) Antibody Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Tropomyosin Receptor Kinase C (TrkC) Antibody Market
34. Recent Developments In The Tropomyosin Receptor Kinase C (TrkC) Antibody Market
35. Tropomyosin Receptor Kinase C (TrkC) Antibody Market High Potential Countries, Segments and Strategies
35.1 Tropomyosin Receptor Kinase C (TrkC) Antibody Market In 2029 - Countries Offering Most New Opportunities
35.2 Tropomyosin Receptor Kinase C (TrkC) Antibody Market In 2029 - Segments Offering Most New Opportunities
35.3 Tropomyosin Receptor Kinase C (TrkC) Antibody Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
